{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T21:22:42Z","timestamp":1773523362801,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["endocrinologydiabetes.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AACE Endocrinology and Diabetes"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.aed.2025.09.002","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T16:36:23Z","timestamp":1757608583000},"page":"304-307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Reclassification of Hypophosphatemic Bone Disease as X-Linked Hypophosphatemia Following Genetic Testing in Adulthood"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-4065-407X","authenticated-orcid":false,"given":"Loay","family":"Kamel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4503-3477","authenticated-orcid":false,"given":"Abdullah","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8257-1260","authenticated-orcid":false,"given":"Ahmed","family":"Elmewafy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5378-5548","authenticated-orcid":false,"given":"Dalal S.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliya A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.aed.2025.09.002_bib1","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1210\/clinem\/dgaf170","article-title":"X-Linked hypophosphatemia management in Adults: an international working group clinical practice guideline","volume":"110","author":"Khan","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.aed.2025.09.002_bib2","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1210\/clinem\/dgaf093","article-title":"X-Linked hypophosphatemia management in children: an international working group clinical practice guideline","volume":"110","author":"Ali","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.aed.2025.09.002_bib3","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jbmr.340","article-title":"A clinician's guide to X-linked hypophosphatemia","volume":"26","author":"Carpenter","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.aed.2025.09.002_bib4","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/EC-13-0103","article-title":"Therapeutic management of hypophosphatemic rickets from infancy to adulthood","volume":"3","author":"Linglart","year":"2014","journal-title":"Endocr Connect"},{"issue":"10189","key":"10.1016\/j.aed.2025.09.002_bib5","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/S0140-6736(19)30654-3","article-title":"Burosumab versus conventional therapy in children with X-linked hypophosphatemia: a randomised, active-controlled, open-label, phase 3 trial","volume":"393","author":"Imel","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.aed.2025.09.002_bib6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/ajmg.1320010111","article-title":"Hypophosphatemic nonrachitic bone disease: an entity distinct from X-linked hypophosphatemia in the renal defect, bone involvement, and inheritance","volume":"1","author":"Scriver","year":"1977","journal-title":"Am J Med Genet"},{"issue":"10116","key":"10.1016\/j.aed.2025.09.002_bib7","first-page":"2415","article-title":"A randomized, double-blind, placebo-controlled, phase 3 trial of burosumab in adults with X-linked hypophosphatemia (XLH)","volume":"391","author":"Insogna","year":"2018","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.aed.2025.09.002_bib8","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/cge.12280","article-title":"Whole exome sequencing unravels disease-causing genes in consanguineous families in Qatar","volume":"86","author":"Fahiminiya","year":"2014","journal-title":"Clin Genet"},{"issue":"4","key":"10.1016\/j.aed.2025.09.002_bib9","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00439-009-0631-z","article-title":"PHEX analysis in 118 pedigrees reveals new genetic clues in hypophosphatemic rickets","volume":"125","author":"Gaucher","year":"2009","journal-title":"Hum Genet"},{"issue":"4","key":"10.1016\/j.aed.2025.09.002_bib10","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.bone.2008.06.002","article-title":"Mutational survey of the PHEX gene in patients with X-linked hypophosphatemic rickets","volume":"43","author":"Ichikawa","year":"2008","journal-title":"Bone"}],"container-title":["AACE Endocrinology and Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050915725001158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050915725001158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T08:42:42Z","timestamp":1765269762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050915725001158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S3050915725001158"],"URL":"https:\/\/doi.org\/10.1016\/j.aed.2025.09.002","relation":{},"ISSN":["3050-9157"],"issn-type":[{"value":"3050-9157","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reclassification of Hypophosphatemic Bone Disease as X-Linked Hypophosphatemia Following Genetic Testing in Adulthood","name":"articletitle","label":"Article Title"},{"value":"AACE Endocrinology and Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aed.2025.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Association of Clinical Endocrinologists. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}